Vasopressin

Generic Name
Vasopressin
Brand Names
Vasostrict
Drug Type
Small Molecule
Chemical Formula
C92H130N28O24S4
CAS Number
11000-17-2
Unique Ingredient Identifier
Y87Y826H08
Background

Vasopressin (arginine-vasopressin or antidiuretic hormone) is a nonapeptide primarily produced in the hypothalamus that exhibits diverse physiological functions related to diuresis, hemodynamic modulation, and behaviour. Vasopressin is very similar to oxytocin, differing in the third and eighth amino acids. Despite a wide variety of functions, exogenous vaso...

Indication

1.诊断和治疗由于缺乏抗利尿激素而引起的尿崩症，也用于其他药物效果不佳的腹部肌肉松弛；

2.脑外科手术后或头颅创伤后多尿的初期治疗；

3.用于食管、胃肠道消化道疾病的急性大出血的辅助治疗。

Associated Conditions
Acute Circulatory Failure
Associated Therapies
Dental Local Anesthesia
Clinical Trials
Related News

NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock

Phase 4
Withdrawn
Conditions
Shock, Septic
Interventions
Drug: Vasopressin
Drug: Norepinephrine
First Posted Date
2015-05-27
Last Posted Date
2017-11-29
Lead Sponsor
University of Arkansas
Registration Number
NCT02454348
Locations
🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Neurobiological Bases of Paternal Nurturance

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Oxytocin
Drug: Vasopressin
Drug: Placebo
First Posted Date
2014-08-22
Last Posted Date
2017-06-05
Lead Sponsor
James K. Rilling, PhD
Target Recruit Count
35
Registration Number
NCT02223429
Locations
🇺🇸

Emory University 1462 Clifton Rd, Atlanta, Georgia, United States

🇺🇸

Emory University Hospital, Atlanta, Georgia, United States

Vasoactive Drugs in Intensive Care Unit

First Posted Date
2014-04-21
Last Posted Date
2024-12-09
Lead Sponsor
University of Chicago
Target Recruit Count
836
Registration Number
NCT02118467
Locations
🇺🇸

University of Chicago Medical Center, Chicago, Illinois, United States

The Role of Vasopressin in the Social Deficits of Autism

Phase 2
Completed
Conditions
Autism Spectrum Disorders
Interventions
Drug: Placebo
Drug: Vasopressin
First Posted Date
2013-10-14
Last Posted Date
2019-05-24
Lead Sponsor
Stanford University
Target Recruit Count
68
Registration Number
NCT01962870
Locations
🇺🇸

Stanford University School of Medicine; Psychiatry and Behavioral Sciences, Stanford, California, United States

Vasopressin Versus Epinephrine in Myomectomy

Phase 3
Completed
Conditions
Uterine Myomas
Interventions
Drug: Epinephrine
Drug: Vasopressin
First Posted Date
2013-05-23
Last Posted Date
2016-01-22
Lead Sponsor
CHA University
Target Recruit Count
60
Registration Number
NCT01861015
Locations
🇰🇷

CHA Gangnam Medical Center, Seoul, Korea, Republic of

Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients

Phase 3
Completed
Conditions
Septic Shock
Interventions
Drug: Norepinephrine
Drug: Vasopressin
First Posted Date
2012-10-31
Last Posted Date
2018-05-18
Lead Sponsor
Instituto do Cancer do Estado de São Paulo
Target Recruit Count
250
Registration Number
NCT01718613
Locations
🇧🇷

Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, Sao Paulo/SP, Brazil

Study of the Use of Misoprostol to Decrease Bleeding During a Myomectomy

Phase 4
Completed
Conditions
Hemorrhage
Interventions
Drug: Misoprostol + vasopressin
Drug: Vasopressin
First Posted Date
2012-10-04
Last Posted Date
2013-02-11
Lead Sponsor
University Hospital of the West Indies
Target Recruit Count
45
Registration Number
NCT01700478
Locations
🇯🇲

University Hospital of the West Indies, Kingston, Jamaica

AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock

Phase 2
Completed
Conditions
Traumatic Shock
Interventions
Drug: Vasopressin
First Posted Date
2012-06-05
Last Posted Date
2019-05-21
Lead Sponsor
University of Pennsylvania
Target Recruit Count
101
Registration Number
NCT01611935
Locations
🇺🇸

Hospital at the Unversity of Pennyslvania, Philadelphia, Pennsylvania, United States

Vasopressin Versus Norepinephrine for the Management of Shock After Cardiac Surgery

Phase 3
Conditions
Shock
Interventions
Drug: Vasopressin
Drug: Norepinephrine
First Posted Date
2012-01-06
Last Posted Date
2013-02-12
Lead Sponsor
University of Sao Paulo
Target Recruit Count
300
Registration Number
NCT01505231
Locations
🇧🇷

Instituto do Coração, São Paulo, Brazil

Discontinuation Order of Vasopressors in Septic Shock

Not Applicable
Terminated
Conditions
Septic Shock
Interventions
Drug: Vasopressin
Drug: Norepinephrine
First Posted Date
2011-12-15
Last Posted Date
2015-01-30
Lead Sponsor
Samsung Medical Center
Target Recruit Count
78
Registration Number
NCT01493102
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy